Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A

Background: Lansoprazole, amoxicillin, and clarithromycin are commonly used drugs for eradication of Helicobacter pylori (H. pylori). A few studies reported that the eradication rate was influenced by the functional polymorphism of CYP2C19, whose product metabolizes proton pomp inhibitors including...

Full description

Bibliographic Details
Main Authors:	Ishida, Yoshiko, Goto, Yasuyuki, Kondo, Takaaki, Kurata, Mio, Nishio, Kazuko, Kawai, Sayo, Osafune, Tomo, Naito, Mariko, Hamajima, Nobuyuki
Format:	Online
Language:	English
Published:	Ivyspring International Publisher 2006
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570618/

id	pubmed-1570618
recordtype	oai_dc
spelling	pubmed-15706182006-09-25 Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A Ishida, Yoshiko Goto, Yasuyuki Kondo, Takaaki Kurata, Mio Nishio, Kazuko Kawai, Sayo Osafune, Tomo Naito, Mariko Hamajima, Nobuyuki Research Paper Background: Lansoprazole, amoxicillin, and clarithromycin are commonly used drugs for eradication of Helicobacter pylori (H. pylori). A few studies reported that the eradication rate was influenced by the functional polymorphism of CYP2C19, whose product metabolizes proton pomp inhibitors including lansoprazole. Ivyspring International Publisher 2006-09-10 /pmc/articles/PMC1570618/ /pubmed/17003844 Text en © Ivyspring International Publisher. This is an open access article. Reproduction is permitted for personal and noncommerical use, provided that the article is in whole, unmodified, and properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Ishida, Yoshiko Goto, Yasuyuki Kondo, Takaaki Kurata, Mio Nishio, Kazuko Kawai, Sayo Osafune, Tomo Naito, Mariko Hamajima, Nobuyuki
spellingShingle	Ishida, Yoshiko Goto, Yasuyuki Kondo, Takaaki Kurata, Mio Nishio, Kazuko Kawai, Sayo Osafune, Tomo Naito, Mariko Hamajima, Nobuyuki Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
author_facet	Ishida, Yoshiko Goto, Yasuyuki Kondo, Takaaki Kurata, Mio Nishio, Kazuko Kawai, Sayo Osafune, Tomo Naito, Mariko Hamajima, Nobuyuki
author_sort	Ishida, Yoshiko
title	Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
title_short	Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
title_full	Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
title_fullStr	Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
title_full_unstemmed	Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A
title_sort	eradication rate of helicobacter pylori according to genotypes of cyp2c19, il-1b, and tnf-a
description	Background: Lansoprazole, amoxicillin, and clarithromycin are commonly used drugs for eradication of Helicobacter pylori (H. pylori). A few studies reported that the eradication rate was influenced by the functional polymorphism of CYP2C19, whose product metabolizes proton pomp inhibitors including lansoprazole.
publisher	Ivyspring International Publisher
publishDate	2006
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570618/
_version_	1611389376101613568

Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A

Similar Items